Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use STIOLTO RESPIMAT safely and effectively. See full prescribing information for STIOLTO RESPIMAT. STIOLTO® RESPIMAT® (tiotropium bromide and olodaterol inhalation spray), for oral inhalation use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
STIOLTO RESPIMAT is a combination of tiotropium bromide and olodaterol indicated for long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Important Limitations of Use STIOLTO RESPIMAT is not indicated to treat acute deteriorations of COPD [see Warnings and Precautions (5.2)]. STIOLTO RESPIMAT is not indicated to treat asthma. The safety and effectiveness of STIOLTO RESPIMAT in asthma have not been established.
- generic_name
- tiotropium bromide and olodaterol
- product_names
- tiotropium bromide and olodaterol
- ndc
- 0597-0155, 0597-0155-28, 0597-0155-61, 0597-0155-31, 0597-0155-70
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en